Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular events
Tzellos, T., Kyrgidis, A., Trigoni, A., Zouboulis, C.C.Volume:
27
Language:
english
Journal:
Journal of the European Academy of Dermatology and Venereology
DOI:
10.1111/jdv.12126
Date:
December, 2013
File:
PDF, 50 KB
english, 2013